The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial

Alzheimer's and Dementia

Volumn 12, Issue 2, 2016, Pages 89-99

  Jia, Jianping ^a,b   Wei, Cuibai ^a   Liang, Junhua ^a   Zhou, Aihong ^a   Zuo, Xiumei ^a   Song, Haiqing ^a   Wu, Liyong ^a   Chen, Xiaochun ^c   Chen, Shengdi ^d   Zhang, Junjian ^e   Wu, Jiang ^f   Wang, Kai ^g   Chu, Lan ^h   Peng, Dantao ⁱ   Lv, Peiyuan ^j   Guo, Hongzhi ^k   Niu, Xiaoyuan ^l   Chen, Yingzhu ^m   Dong, Wanli ⁿ   Han, Xiujie ^o   Fang, Boyan ^p   Peng, Mao ^a   Li, Dan ^a   Jia, Qian ^a   Huang, Liyuan ^a   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e WUHAN UNIVERSITY   (China)

^f JILIN UNIVERSITY   (China)

^g ANHUI MEDICAL UNIVERSITY   (China)

^h GUIZHOU MEDICAL UNIVERSITY   (China)

ⁱ BEIJING HOSPITAL   (China)

^j HEBEI GENERAL HOSPITAL   (China)

^k SHANDONG UNIVERSITY   (China)

^l SHANXI MEDICAL UNIVERSITY   (China)

^m YANGZHOU UNIVERSITY   (China)

ⁿ SOOCHOW UNIVERSITY   (China)

^o Shuguang Hospital of Anshan   (China)

^p JINZHOU MEDICAL UNIVERSITY   (China)

more..

Author keywords

Cerebral small vessel disease; DL 3 n Butylphthalide; Multicentre study; Randomized controlled trial; Vascular cognitive impairment without dementia

Indexed keywords

BUTYLPHTHALIDE; DL 3 N BUTYLPHTHALIDE; UNCLASSIFIED DRUG; 3-N-BUTYLPHTHALIDE; BENZOFURAN DERIVATIVE; NEUROPROTECTIVE AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAREGIVER; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FRACTURE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCORTICAL ISCHEMIC SMALL VESSEL DISEASE; TRANSIENT ISCHEMIC ATTACK; VASCULAR COGNITIVE IMPAIRMENT; CEREBROVASCULAR DISEASE; CHINA; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST;

AGED; BENZOFURANS; CEREBRAL SMALL VESSEL DISEASES; CHINA; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS;

EID: 84957842671     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.04.010     Document Type: Article

References (49)

1. C. Wentzel, K. Rockwood, C. MacKnight, V. Hachinski, D.B. Hogan, H. Feldman, and et al. Progression of impairment in patients with vascular cognitive impairment without dementia Neurology 57 2001 714 716
2. B.C. Stephan, F.E. Matthews, K.T. Khaw, C. Dufouil, and C. Brayne Beyond mild cognitive impairment: Vascular cognitive impairment, no dementia (VCIND) Alzheimers Res Ther 1 2009 4
3. K. Rockwood, C. Wentzel, V. Hachinski, D.B. Hogan, C. MacKnight, and I. McDowell Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the Canadian Study of Health and Aging Neurology 54 2000 447 451
4. J.L. Ingels, C. Wentzel, J.D. Fisk, and K. Rockwood Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment without dementia Stroke 33 2002 1999 2002
5. B.L. Plassman, K.M. Langa, G.G. Fisher, S.G. Heeringa, D.R. Weir, M.B. Ofstedal, and et al. Prevalence of cognitive impairment without dementia in the United States Ann Intern Med 148 2008 427 434
6. J.P. Jia, A.H. Zhou, C.B. Wei, X.F. Jia, F. Wang, F. Li, and et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese Alzheimers Dement 10 2014 439 447
7. L. Pantoni Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges Lancet Neurol 9 2010 689 701
8. H.L. Xu, and Y.P. Feng Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats Yao Xue Xue Bao 36 2001 329 333 (in Chinese with English abstract, Pubmed PMID:12584852)
9. Y. Peng, X.K. Zeng, Y.P. Feng, and X.L. Wang Antiplatelet and antithrombotic activity of L-3-n-butylphthalide in rats J Cardiovasc Pharmacol 43 2004 876 881
10. G.X. Dong, and Y.P. Feng Effects of NBP on ATPase and anti-oxidant enzymes activities and lipid peroxidation in transient focal cerebral ischemic rats Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24 2002 93 97 (in Chinese with English abstract, Pubmed PMID:12905849)
11. H.L. Xu, and Y.P. Feng Effects of 3-n-butylphthalide (NBP) on pial arterioles in focal cerebral ischemia rats Yao Xue Xue Bao 34 1999 172 175 (in Chinese with English abstract)
12. C.L. Liu, S.J. Liao, J.S. Zeng, J.W. Lin, C.X. Li, L.C. Xie, and et al. Dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP J Neurol Sci 260 2007 106 113
13. L.Y. Zhang, and Y.P. Feng Effect of dl-3-n-butylphthalide (NBP) on life span and neurological deficit in SHRsp rats Yao Xue Xue Bao 31 1996 18 23 (in Chinese with English abstract, Pubmed PMID:8762459)
14. L.Y. Cui, X.Q. Liu, Y.C. Zhu, D.S. Fan, R.P. Xie, Y. Shen, and et al. Effects of dl-3-Butylphthalide on treatment of acute ischemic stroke with moderate symptoms: a multi-center, randomized, double-blind, placebo-control trial Chin J Neurol 38 2005 251 254 (in Chinese with English abstract)
15. L.Y. Cui, S.W. Li, C.Z. Lv, Q. Dong, P. Dong, L.F. Shi, and et al. The multicentric randomized study of dl-3-butylphthalide in the treatment of acute moderate ischemic stroke Chin J Cerebrovasc Dis 2 2005 112 115 (in Chinese with English abstract)
16. T. Guo, R.L. Shen, Y.Z. Wu, and J.F. Teng The effect of dl-butylphthalide on NR2B and synaptophysin in hippocampus of aged rats after chronic cerebral hypoperfusion Chin J Pract Nerv Dis 10 2007 60 62 (in Chinese with English abstract)
17. Y. Peng, J. Sun, S. Hon, A.N. Nylander, W.M. Xia, Y.P. Feng, and et al. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease J Neurosci 30 2010 8180 8189
18. D. Hu, L.Y. Zhang, and Y.P. Feng Effect of dl-3-n-butylphthalide on memory disturbance induced by focal cerebral ischemia in rats Chin J Pharmacol Toxicol 11 1997 14 16 (in Chinese with English abstract)
19. G.C. Román, T. Erkinjuntti, A. Wallin, L. Pantoni, and H.C. Chui Subcortical ischaemic vascular dementia Lancet Neurol 1 2002 426 436
20. L. Pantoni, and M. Simoni Pathophysiology of cerebral small vessels in vascular cognitive impairment Int Psychogeriatr 15 2003 59 65
21. B. Winblad, K. Palmer, M. Kivipelto, V. Jelic, L. Fratiglioni, L.O. Wahlund, and et al. Mild cognitive impairment - beyond controversies, towards a consensus: Report of the international working group on mild cognitive impairment J Intern Med 256 2004 240 246
22. American Psychiatric Association DSM-IV: diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Association Washington, DC
23. C.P. Hughes, L. Berg, W.L. Danziger, L.A. Coben, and R.L. Martin A new clinical scale for the staging of dementia Br J Psychiatry 140 1982 566 572
24. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
25. M.Y. Zhang, R. Katzman, D. Salmon, H. Jin, G.J. Cai, Z.Y. Wang, and et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education Ann Neurol 27 1990 428 437
26. S. Salloway, S. Ferris, A. Kluger, R. Goldman, T. Griesing, D. Kumar, and et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial Neurology 63 2004 651 657
27. F. Fazekas, J.B. Chawluk, A. Alavi, H.I. Hurtig, and R.A. Zimmerman MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging AJR Am J Roentgenol 149 1987 351 356
28. P. Scheltens, D. Leys, F. Barkhof, D. Huglo, H.C. Weinstein, P. Vermersch, and et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates J Neurol Neurosurg Psychiatry 55 1992 967 972
29. H.L. Wang, X. Yu, S.R. Li, Y.F. Chen, H.D. Li, and J. He The cognitive subscale of Alzheimer's disease assessment scale, Chinese version in staging of Alzheimer disease Alzheimer Dis Assoc Disord 18 2004 231 235
30. L.S. Schneider, J.T. Olin, R.S. Doody, C.M. Clark, J.C. Morris, B. Reisberg, and et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Alzheimer Dis Assoc Disord 11 1997 S22 32
31. P. Chen, E.S. Yu, M. Zhang, W.T. Liu, R. Hill, and R. Katzman ADL dependence and medical conditions in Chinese older persons: A population-based survey in Shanghai, China J Am Geriatr Soc 43 1995 378 383
32. J.L. Cummings The Neuropsychiatric Inventory: assessing psychopathology in dementia patients Neurology 48 1997 S10 S16
33. R.C. Petersen, R.G. Thomas, M. Grundman, D. Bennett, R. Doody, S. Ferris, and et al. Vitamin E and donepezil for the treatment of mild cognitive impairment N Engl J Med 352 2005 2379 2388
34. J.M. Orgogozo, A.S. Rigaud, A. Stöffler, H.J. Möbius, and F. Forette Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebo-controlled trial (MMM 300) Stroke 33 2002 1834 1839
35. H. Kavirajan, and L.S. Schneider Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: A meta-analysis of randomised controlled trials Lancet Neurol 6 2007 782 792
36. J.S. Meyer, G.L. Xu, J. Thornby, M.H. Chowdhury, and M. Quach Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke 33 2002 1981 1985
37. A.P. Auchus, H.R. Brashear, S. Salloway, A.D. Korczyn, P.P. De Deyn, and C. Gassmann-Mayer Galantamine treatment of vascular dementia: A randomized trial Neurology 69 2007 448 458
38. C. Ballard, M. Sauter, P. Scheltens, Y. He, F. Barkhof, E.C. van Straaten, and et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: The VantagE study Curr Med Res Opin 24 2008 2561 2574
39. D. Wilkinson, R. Doody, R. Helme, K. Taubman, J. Minzter, A. Kertesz, and et al. Donepezil in vascular dementia: A randomized, placebo-controlled study Neurology 61 2003 479 486
40. Aguilar M., Roman G., Black S. Efficacy and safety of donepezil in vascular dementia: Results from the largest double-blind trial in vascular dementia. Proceedings of the 10th International Conference on Alzheimer's Disease and Related Disorders, Madrid, Spain; July 15-20, 2006; P4-439.
41. C. Iadecola, L. Park, and C. Capone Threats to the mind: aging, amyloid, and hypertension Stroke 40 2009 S40 S44
42. M. Dichgans, and V. Zietemann Prevention of vascular cognitive impairment Stroke 43 2012 3137 3146
43. J. Xu, Y.Y. Wang, N. Li, L.J. Xu, H.Y. Yang, and Z. Yang L-3-n-butylphthalide improves cognitive deficits in rats with chronic cerebral ischemia Neuropharmacology 62 2012 2424 2429
44. Y. Peng, S.F. Xu, G.Q. Chen, L. Wang, Y.P. Feng, and X.L. Wang L-3-n-butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats J Pharmacol Exp Ther 321 2007 902 910
45. P. Newhouse, K. Kellar, P. Aisen, H. White, K. Wesnes, E. Coderre, and et al. Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial Neurology 78 2012 91 101
46. R.S. Doody, S.H. Ferris, S. Salloway, Y. Sun, R. Goldman, W.E. Watkins, and et al. Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial Neurology 72 2009 1555 1561
47. T.T. Ashburn, and K.B. Thor Drug repositioning: identifying and developing new uses for existing drugs Nat Rev Drug Discov 3 2004 673 683
48. Z.H. Tan, H.C. Lan, Q. Yang, J. Chen, S.P. Mao, Y.F. Zha, and et al. Clinical research of early intervention of modified shuyu pill in vascular cognitive impairment no dementia Zhongguo Zhong Xi Yi Jie He Za Zhi 33 2013 27 30 (in Chinese with English abstract, PMID:23596781)
49. K. Narasimhalu, S. Effendy, C.H. Sim, J.M. Lee, I. Chen, S.B. Hia, and et al. A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease Acta Neurol Scand 121 2010 217 224